Toggle Main Menu Toggle Search

Open Access padlockePrints

Beyond insulin: Unraveling the complex interplay of ER stress, oxidative damage, and CFTR modulation in CFRD

Lookup NU author(s): Professor James Shaw

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2024 The Author(s)CF-related diabetes (CFRD) is a prevalent comorbidity in people with Cystic Fibrosis (CF), significantly impacting morbidity and mortality rates. This review article critically evaluates the current understanding of CFRD molecular mechanisms, including the role of CFTR protein, oxidative stress, unfolded protein response (UPR) and intracellular communication. CFRD manifests from a complex interplay between exocrine pancreatic damage and intrinsic endocrine dysfunction, further complicated by the deleterious effects of misfolded CFTR protein on insulin secretion and action. Studies indicate that ER stress and subsequent UPR activation play critical roles in both exocrine and endocrine pancreatic cell dysfunction, contributing to β-cell loss and insulin insufficiency. Additionally, oxidative stress and altered calcium flux, exacerbated by CFTR dysfunction, impair β-cell survival and function, highlighting the significance of antioxidant pathways in CFRD pathogenesis. Emerging evidence underscores the importance of exosomal microRNAs (miRNAs) in mediating inflammatory and stress responses, offering novel insights into CFRD's molecular landscape. Despite insulin therapy remaining the cornerstone of CFRD management, the variability in response to CFTR modulators underscores the need for personalized treatment approaches. The review advocates for further research into non-CFTR therapeutic targets, emphasizing the need to address the multifaceted pathophysiology of CFRD. Understanding the intricate mechanisms underlying CFRD will pave the way for innovative treatments, moving beyond insulin therapy to target the disease's root causes and improve the quality of life for individuals with CF.


Publication metadata

Author(s): Umashankar B, Eliasson L, Ooi CY, Kim KW, Shaw JAM, Waters SA

Publication type: Review

Publication status: Published

Journal: Journal of Cystic Fibrosis

Year: 2024

Volume: 23

Issue: 5

Pages: 842-852

Print publication date: 01/09/2024

Online publication date: 18/06/2024

Acceptance date: 04/06/2024

ISSN (print): 1569-1993

ISSN (electronic): 1873-5010

Publisher: Elsevier B.V.

URL: https://doi.org/10.1016/j.jcf.2024.06.004

DOI: 10.1016/j.jcf.2024.06.004


Share